ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 120 filers reported holding ITEOS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,646,289 | -17.3% | 150,346 | 0.0% | 0.01% | -25.0% |
| Q2 2023 | $1,990,581 | -2.7% | 150,346 | 0.0% | 0.01% | +9.1% |
| Q1 2023 | $2,046,209 | -30.3% | 150,346 | 0.0% | 0.01% | -38.9% |
| Q4 2022 | $2,936,257 | +2.5% | 150,346 | 0.0% | 0.02% | -5.3% |
| Q3 2022 | $2,864,000 | -7.5% | 150,346 | 0.0% | 0.02% | +5.6% |
| Q2 2022 | $3,097,000 | -36.0% | 150,346 | 0.0% | 0.02% | -35.7% |
| Q1 2022 | $4,838,000 | -30.9% | 150,346 | 0.0% | 0.03% | -17.6% |
| Q4 2021 | $7,000,000 | +72.5% | 150,346 | 0.0% | 0.03% | +88.9% |
| Q3 2021 | $4,059,000 | +5.3% | 150,346 | 0.0% | 0.02% | +5.9% |
| Q2 2021 | $3,856,000 | -25.0% | 150,346 | 0.0% | 0.02% | -22.7% |
| Q1 2021 | $5,139,000 | +1.1% | 150,346 | 0.0% | 0.02% | +15.8% |
| Q4 2020 | $5,085,000 | +23.0% | 150,346 | -10.3% | 0.02% | +11.8% |
| Q3 2020 | $4,134,000 | – | 167,562 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $52,174,000 | 19.87% |
| MPM BioImpact LLC | 1,745,943 | $33,260,000 | 7.88% |
| Boxer Capital, LLC | 2,154,058 | $41,035,000 | 2.31% |
| TANG CAPITAL MANAGEMENT LLC | 937,500 | $17,859,000 | 2.19% |
| RA Capital Management | 4,417,259 | $84,149,000 | 1.80% |
| BVF INC/IL | 1,810,835 | $34,496,000 | 1.42% |
| Zebra Capital Management LLC | 12,271 | $234,000 | 0.89% |
| Integral Health Asset Management, LLC | 195,000 | $3,715,000 | 0.72% |
| Prairiewood Capital, LLC | 32,269 | $615,000 | 0.51% |
| DAFNA Capital Management LLC | 97,560 | $1,859,000 | 0.50% |